Figure 2: Kaplan–Meier curves showing PFS, OS, and TTF in our cohort. PFS: Progression-free survival, OS: Overall survival, TTF: Time to treatment failure, CI: Confidence interval, NR: Not reached. (a) PFS of patients with advanced renal cell carcinoma treated with pazopanib at a starting dose of 400 mg. (b) OS of patients with advanced renal cell carcinoma treated with pazopanib at a starting dose of 400 mg. (c) TTF of patients with advanced renal cell carcinoma treated with pazopanib at a starting dose of 400 mg